Transplantation Immunology 1. Indicate by reference to the genetic mapping of the human HLA system, the probability of finding HLA identical siblings versus parents and unrelated individuals. HLA Human leukocyte antigen Also known as the human MHC (major histocompatibility complex) Antigen on the surface of the cell that enables the leukocyte cells of a different person to know that it is non self. E.g. The recipients leukocytes will recognise a donor’s tissue as foreign based on the HLA Until 1999 there were about 1000 HLA alleles discovered The main target of cellular immune response in organ donation and cause rejection of tissue in unrelated people. Two classes o Class I – presents antigens to CD8 (cytotoxic) T cells o Class II – presents antigens to CD4 (helper) T cells Three Class I HLA genes – A – B – C Three Class II HLA genes – DP – DQ – DR Each person inherits 2 copies of each gene locus therefore will have 6 Class I and 6 Class 2 loci In the human population there are multiple alleles for each gene locus. E.g 151 known HLA A alleles, 301 known HLA B alleles. This is known as polymorphism A typical person is likely to inherit 2 different alleles of many of the MHC loci which is beneficial as it increases the likelihood the person can present a range of different antigenic peptides that can be presented to the T cells. Mendelian inheritance says that there is a 25% chance offspring will inherit the same HLA type. Polymorphism of the HLA gene means that there can be much variation so there is a higher chance of finding a matched sibling to a parent to an unrelated person. The HLA alleles found on one chromosome is termed a haplotype Testing for HLA typing involves using serum that contains HLA antigens. If the donor’s serum reacts with the patient’s cells, the individuals are incompatible. Crossmatching is used to detect if a donor’s antibodies will react with the recipient’s antigens and therefore reject the transplant In heart transplants it is impractical to distribute based on HLA typing due to limited availability of the organ Prevention of rejection o o o o o HLA typing Immunosuppression Autologous transplantation – using own tissue. E.g. cultivating own bone marrow and then transplanting Tissue engineering Immunomodulation – a substance that alters the immune response by augmenting or reducing the ability of the immune system to produce antibodies against the antigen. E.g. corticosteroids, cytotoxic agents, immunoglobulins